Therapy Areas: Autoimmune
19 October 2021 - - The US Food and Drug Administration approved the first interchangeable biosimilar product to treat certain inflammatory diseases, the agency said.

Cyltezo (a...
15 October 2021 - - US-based Amber Specialty Pharmacy will begin dispensing Tavneos (avacopan), a first of its kind orally-administered selective complement 5a receptor inhibitor, as an adjunctive tre...
13 October 2021 - - The first patient has been dosed in the company's Phase 1 study of RPTR-168 (PRIME IL-12) in patients with select relapsed or refractory human papillomavirus -16-positive tumo...
12 October 2021 - - A manuscript describing US-based biopharmaceutical company Humanigen, Inc's (NASDAQ: HGEN) budget impact model for the treatment of patients hospitalized with COVID-19 is avai...
5 October 2021 - - US-based T-cell immunotherapy company Atara Biotherapeutics, Inc. (NASDAQ: ATRA) and France-based pharmaceutical and cosmetics company Pierre Fabre have inked an exclusive commercia...
5 October 2021 - - US-based clinical-stage biopharmaceutical company Xencor, Inc. (NASDAQ: XNCR) has forged an exclusive collaboration and worldwide license agreement with Johnson and Johnson's (...
Related Headlines